Lexicon Pharma says its irritable bowel syndrome drug LX1031 met study goal; shares jump Lexicon Pharmaceuticals Inc. said Friday an irritable bowel syndrome ...
SINGAPORE (Reuters Life!) - Who says healthy has to be boring? A new cookbook from top Australian chefs shows it is possible to ...
A thousand miles from the health care debate in Washington, Dr. Don Klitgaard and his colleagues are carrying out their own reform in a small Iowa community. They've reorganized their clinic so nurses bird-dog patients whose health problems, if ignored, could send ...
About 47 million adults in the United States-about 25 percent of the population-have metabolic syndrome. Despite this shocking statistic, only a minority would probably be able to identify exactly what this condition entails. Metabolic syndrome is the name for a group of ...
NEW YORK (Reuters Health) - A few cups of coffee everyday may help slow the progression of liver disease associated with long-term infection with the hepatitis C virus, a new study hints. Researchers found that among 766 patients with hepatitis C-related liver ...
St. Louis Blues center T.J. Oshie will miss the next two weeks of the National Hockey League season following an appendectomy Saturday morning. Just hours after playing in a 3-1 victory over Minnesota on Friday night, the 22-year-old American underwent the operation ...
NEW YORK (Reuters) - Nearly half of patients who completed 56 weeks of treatment with Orexigen Therapeutics Inc's experimental obesity treatment, Contrave, lost at least 10 percent of their weight in a late-stage study and the drug also appeared to help cholesterol ...
NEW YORK (Reuters Health) - Obese adults may shed more weight with the diabetes drug liraglutide than with the weight-loss drug orlistat (Xenical, Alli), suggests a study in The Lancet this week. The finding that liraglutide was superior to orlistat was "unexpected," ...
NEW YORK (Reuters Health) - Cholesterol-lowering statin drugs do not reduce the risk of diabetes and might modestly elevate the chances of developing the condition, researchers found in a pooled analysis of trial data. "Contrary to our expectation," lead investigator Dr. Swapnil ...
A hormone drug licensed for diabetes also helps obese people lose weight when used in combination with a low-fat diet and physical exercise, according to a trial published online on Friday by The Lancet. Liraglutide, marketed as Victoza, outperformed the established anti-obesity ...
BOSTON (Reuters) - Long-acting insulin works better than other types of injections for people who need more than pills for their type 2 diabetes, researchers reported on Thursday. Long-acting Levemir insulin, given at bedtime, and NovoRapid insulin injections, given three times a ...
Researchers in the United States have found another good reason to go to the local espresso bar: several cups of coffee a day could halt the progression of liver disease, a study showed Wednesday. Sufferers of chronic hepatitis C and advanced liver ...
